| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.097 | 0.02 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |